- Home
- IBM vs NVS Comparison
IBM vs NVS Comparison
Compare IBM & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBM
- NVS
- Stock Information
- Founded
- IBM 1911
- NVS 1895
- Country
- IBM United States
- NVS Switzerland
- Employees
- IBM N/A
- NVS N/A
- Industry
- IBM Computer Manufacturing
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- IBM Technology
- NVS Health Care
- Exchange
- IBM Nasdaq
- NVS Nasdaq
- Market Cap
- IBM 205.9B
- NVS 230.5B
- IPO Year
- IBM N/A
- NVS 1991
- Fundamental
- Price
- IBM $224.70
- NVS $97.52
- Analyst Decision
- IBM Hold
- NVS Hold
- Analyst Count
- IBM 13
- NVS 6
- Target Price
- IBM $217.54
- NVS $121.25
- AVG Volume (30 Days)
- IBM 3.6M
- NVS 1.3M
- Earning Date
- IBM 01-29-2025
- NVS 01-31-2025
- Dividend Yield
- IBM 2.97%
- NVS 3.87%
- EPS Growth
- IBM N/A
- NVS 130.53
- EPS
- IBM 6.86
- NVS 8.58
- Revenue
- IBM $62,580,000,000.00
- NVS $49,940,000,000.00
- Revenue This Year
- IBM $2.58
- NVS $10.38
- Revenue Next Year
- IBM $5.05
- NVS $4.36
- P/E Ratio
- IBM $32.90
- NVS $11.10
- Revenue Growth
- IBM 2.30
- NVS 8.92
- 52 Week Low
- IBM $162.62
- NVS $92.35
- 52 Week High
- IBM $239.35
- NVS $120.92
- Technical
- Relative Strength Index (RSI)
- IBM 54.15
- NVS 38.60
- Support Level
- IBM $217.38
- NVS $97.39
- Resistance Level
- IBM $226.71
- NVS $99.78
- Average True Range (ATR)
- IBM 3.88
- NVS 1.09
- MACD
- IBM 0.05
- NVS 0.27
- Stochastic Oscillator
- IBM 83.39
- NVS 16.09
About IBM International Business Machines Corporation
IBM looks to be a part of every aspect of an enterprise's IT needs. The company primarily sells software, IT services, consulting, and hardware. IBM operates in 175 countries and employs approximately 350,000 people. The company has a robust roster of 80,000 business partners to service 5,200 clients, which includes 95% of all Fortune 500. While IBM is a B2B company, IBM's outward impact is substantial. For example, IBM manages 90% of all credit card transactions globally and is responsible for 50% of all wireless connections in the world.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.